India – Talk Bio

Actionable Insights Powered by AI

AstraZeneca Ends Manufacturing License at Indian Plant and Exits Site as Part of Global Strategy

1 week ago talkbio0Tagged AstraZeneca, Bangalore plant, Contract agreement, Drug Industry, global strategy, India, Manufacturing, manufacturing license, Site of exit

AstraZeneca; India; manufacturing license; site exit; Bangalore plant; contract manufacturing; global strategy; pharmaceutical industry

BioSpace Presents the World Atlas of GLP-1s

6 months ago talkbio0Tagged BioSpace, Brazil, Cervical Atlas, China, Eli Lilly, GLP-1s, Glucagon-Like Peptide 1, India, Nordisk, Wegovy, World

Eli Lilly, Wegovy, India, China, BioSpace, World, Cervical Atlas, GLP-1s, Nordisk, Glucagon-Like Peptide 1, Brazil, India

Amgen expands Indian footprint with $200M tech hub

7 months ago talkbio0Tagged amgen, Aortic Valve Insufficiency, Data Science, India, India 's, Site, Technology

Amgen, India, Technology, Site, Data Science, Aortic Valve Insufficiency, India ‘s

Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business

9 months ago talkbio0Tagged capsule (pharmacologic), China, Exit Strategy, expansion, gelatin, India, Lonza

Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy